ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 44 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $28,000 | – | 59,500 | +16900.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 350 | -89.2% | 0.00% | – |
Q3 2018 | $2,000 | -98.3% | 3,250 | -98.3% | 0.00% | – |
Q2 2018 | $119,000 | +11800.0% | 186,428 | +5383.2% | 0.00% | – |
Q1 2018 | $1,000 | – | 3,400 | +3405.2% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 97 | -99.4% | 0.00% | – |
Q1 2016 | $33,000 | +1000.0% | 17,140 | +1495.9% | 0.00% | – |
Q4 2015 | $3,000 | -94.4% | 1,074 | -96.5% | 0.00% | – |
Q3 2015 | $54,000 | +980.0% | 30,973 | +1353.4% | 0.00% | – |
Q2 2015 | $5,000 | -94.7% | 2,131 | -94.4% | 0.00% | – |
Q1 2015 | $94,000 | – | 38,394 | +319850.0% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 12 | -94.7% | 0.00% | – |
Q3 2014 | $1,000 | – | 226 | +133.0% | 0.00% | – |
Q2 2014 | $0 | – | 97 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
Summit X, LLC | 11,000 | $7,000 | 0.01% |
SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |